Schering-Plough Corp

Article Abstract:

Schering-Plough Corp manufactures prescription and non-prescription drugs, animal health care products and skin care products. Four insiders disposed of 9,100 shares at $60.56 to $65.88 each from Mar 11 to Apr 30, 1993. The latest sales are noteworthy because similar distributions occurred last Apr 1993 and the number of sellers increased. The insider sales also represented a substantial 39% of the sellers' collective holdings. Caution is recommended for the issue.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Bristol-Myers Squibb Co

Article Abstract:

The recent divestment by two insiders of over 130,982 shares in Bristol-Myers Squibb Co (Bristol-Myers) is a reflection of the pharmaceutical firm's precarious financial position. Although Bristol-Myers shares were trading in the $80 range in 1992, the two sold their shares at low prices ranging from $57.88 to $59.50. This indicated that there is a prevailing pessimism regarding prospects for any major turnaround.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Abbott Laboratories

Article Abstract:

Abbott Laboratories is a manufacturer of human pharmaceuticals, nutrional products and hospital and laboratory products. Four insiders have bought 9,250 shares since Feb 8, 1993, at the $23.50 to $28.75 range. The purchases occurred after the drug sector suffered a price decline. Abbott's insider buys indicate the possibility of a recovery.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: